Teplizumab (the Therapy that Delays T1D By Nearly 3 Years) Isn’t Approved…Yet
The FDA issued a letter to Provention Bio for the use of teplizumab to delay T1D in at-risk individuals, meaning…
At ADA, Breakthrough T1D-Funded Research Takes Center Stage
There were a number of fantastic results at the ADA’s Scientific Sessions. Here is a video and a summary of…
Marilyn and Gerald Fishbone: A Lifetime of Generosity and Service
Marilyn and Gerald Fishbone know first-hand how incredible research changes the lives of people with type 1 diabetes (T1D). For…
Video: ADA’s Scientific Sessions: Day 4
Here is Dr. Camillo Ricordi to share his key takeaways from day 4 from the American Diabetes Association's Scientific Sessions.
ADA’s Scientific Sessions: Day 3
Here are Drs. Jennifer Sun, Dana Lewis, and Christine Wang to share their key takeaways from day 3, with their…
ADA’s Scientific Sessions: Day 2
Drs. Danny Chou, Peter Arvan, Jeffrey Millman, and Efsun Arda will share their key takeaways from day 2, with their…
ADA’s Scientific Sessions: Day 1
Here are Drs. Candace Reno and Luiza Caramori share their key takeaways from day 1, with their commentary in the…
Artificial Intelligence Identifies T1D Risk Factors in Children
Breakthrough T1D and IBM Research have published their first paper, applying world-class computing power to identify factors leading to the…
Diabetes-Friendly Summer Recipes for Family and Friends
We asked. You delivered. Nine summertime, diabetes-friendly recipes from members of the Breakthrough T1D community. Bonus: most require no cooking!
Breakthrough T1D Heads, Virtually, to ADA’s 81st Scientific Sessions
At the ADA's 81st Scientific Sessions, healthcare professionals will gather at one of the largest conferences of diabetes researchers in…
